EIS Session 1: Innovation in Treatment Modalities (I) – Development and validation of biomarkers and surrogate endpoints. A regulatory view
Chairperson(s): Anat Loewenstein, Kourous Rezaei – Author/Speaker: Kerstin Wickstrom
Members must be logged in to access On Demand content.
EIS Session 1: Innovation in Treatment Modalities (I) – Beyond Vabysmo and EyleaHD – Is innovation needed in wet AMD?
Chairperson(s): Anat Loewenstein, Kourous Rezaei – Author/Speaker: Laurent Fischer
EIS Session 1: Innovation in Treatment Modalities (I) – AbbVie/REGENXBIO-314: One-time gene therapy for the treatment of degenerative diseases of the retina
Chairperson(s): Anat Loewenstein, Kourous Rezaei – Author/Speaker: Ramin Valian
EIS Session 1: Innovation in Treatment Modalities (I) – A commitment to addressing unmet needs in eye care disease
Chairperson(s): Anat Loewenstein, Kourous Rezaei – Author/Speaker: Mathias Schifflers
EIS Session 1: Innovation in Treatment Modalities (I) – Bayer’s vision for the future of ophthalmology
Chairperson(s): Anat Loewenstein, Kourous Rezaei – Author/Speaker: Sergio Leal
EIS Session 1: Innovation in Treatment Modalities (I) – Innovation in large molecules
Chairperson(s): Anat Loewenstein, Kourous Rezaei – Author/Speaker: Sascha Fauser
EIS Session 2: Innovation in Treatment Modalities (II) – Next generation drug delivery to the back of the eye
Chairperson(s): Frank G. Holz, Ramin Tadayoni – Author/Speaker: Justin Creel
EIS Session 2: Innovation in Treatment Modalities (II) – Innovation in treating diabetic retinopathy: A novel, topically-delivered selective integrin inhibitor
Chairperson(s): Frank G. Holz, Ramin Tadayoni – Author/Speaker: David Tanzer
EIS Session 2: Innovation in Treatment Modalities (II) – Innovation in treatment for Geographic Atrophy: Avacincaptad pegol anti-C5 complement inhibition
Chairperson(s): Frank G. Holz, Ramin Tadayoni – Author/Speaker: Erin Henry
EIS Session 4: Innovations in Retinal Surgery – Driving surgeon-led innovation at the heart of a global device business
Chairperson(s): Alistair Laidlaw, Grazia Pertile – Author/Speaker: Pierre Billardon
EIS Session 4: Innovations in Retinal Surgery – Innovation lights the path to sight: A surgical anthropologists journey
Chairperson(s): Alistair Laidlaw, Grazia Pertile – Author/Speaker: Paul Hallen
EIS Session 4: Innovations in Retinal Surgery – Innovation as a key element in addressing climate change, using the PFAS-ban debate as an example
Chairperson(s): Alistair Laidlaw, Grazia Pertile – Author/Speaker: Helge Menz
EIS Session 5: Innovations in Imaging and AI – ShareLoch: design & implementation of a clinical data warehouse for AI product development
Chairperson(s): Frank G. Holz, Ramin Tadayoni – Author/Speaker: Anne Marie Cairns
EIS Session 5: Innovations in Imaging and AI – Federated deployment of Geographic Atrophy screening and segmentation models for clinical trial pre-screening
Chairperson(s): Frank G. Holz, Ramin Tadayoni – Author/Speaker: Blaise Thomson
EIS Session 5: Innovations in Imaging and AI – Detection of Diseases and Systemic Biomarkers in Photos of External Eyes
Chairperson(s): Frank G. Holz, Ramin Tadayoni – Author/Speaker: Naama Hammel
EIS Session 5: Innovations in Imaging and AI – Imaging and AI: making data work for you
Chairperson(s): Frank G. Holz, Ramin Tadayoni – Author/Speaker: Stephanie Magazzeni
EIS Session 5: Innovations in Imaging and AI – The PRIMA Bionic Vision System for patients with Geographic Atrophy
Chairperson(s): Frank G. Holz, Ramin Tadayoni – Author/Speaker: Ralf Hornig
Uveitis I: Diagnosis, work-up and investigational procedures – Fluorescein and Indocyanine angiography for global appraisal of posterior uveitis
Chairperson(s): Carlos Pavesio, Carl P. Herbort Jr – Author/Speaker: Carl P. Herbort Jr
Uveitis I: Diagnosis, work-up and investigational procedures – Investigational work-up of posterior uveitis
Chairperson(s): Carlos Pavesio, Carl P. Herbort Jr – Author/Speaker: William Tucker
Uveitis I: Diagnosis, work-up and investigational procedures – Non-invasive imaging modalities – SD-OCT, EDI-OCT, FAF, OCT-A
Chairperson(s): Carlos Pavesio, Carl P. Herbort Jr – Author/Speaker: Piergiorgio Neri
Uveitis I: Diagnosis, work-up and investigational procedures – Glimpses into retinal vasculitis
Chairperson(s): Carlos Pavesio, Carl P. Herbort Jr – Author/Speaker: Ahmed Abu El-Asrar
Uveitis I: Diagnosis, work-up and investigational procedures – Clinical assessment of posterior uveitis
Chairperson(s): Carlos Pavesio, Carl P. Herbort Jr – Author/Speaker: Ilknur Tugal-Tutkun
The Role Of Multimodal Imaging In Retinal Diseases – The use of imaging and imaging analysis in other retinal diseases, including diabetic eye disease (Part 2)
Chairperson(s): Giovanni Staurenghi – Author/Speaker: Gemmy Cheung
The Role Of Multimodal Imaging In Retinal Diseases – Imaging in ocular oncology (Part 2)
Chairperson(s): Giovanni Staurenghi – Author/Speaker: Marco Pellegrini
The Role Of Multimodal Imaging In Retinal Diseases – Multimodal imaging in uveitis (Part 2)
Chairperson(s): Giovanni Staurenghi – Author/Speaker: Alessandro Invernizzi
The Role Of Multimodal Imaging In Retinal Diseases – Best practice in imaging AMD (Part 2)
Chairperson(s): Giovanni Staurenghi – Author/Speaker: Francesco Romano
The Role Of Multimodal Imaging In Retinal Diseases – Introduction
Chairperson(s): Giovanni Staurenghi – Author/Speaker: Giovanni Staurenghi
The Role Of Multimodal Imaging In Retinal Diseases – Multimodal imaging in uveitis (Part 1)
Chairperson(s): Giovanni Staurenghi – Author/Speaker: Ester Carreño
The Role Of Multimodal Imaging In Retinal Diseases – The use of imaging and imaging analysis in other retinal diseases, including diabetic eye disease (Part 1)
Chairperson(s): Giovanni Staurenghi – Author/Speaker: Mariacristina Parravano
The Role Of Multimodal Imaging In Retinal Diseases – Imaging in ocular oncology (Part 1)
Chairperson(s): Giovanni Staurenghi – Author/Speaker: Ann Schalenbourg